[Immunopharmacological activity of xymedone in patients with atopic bronchial asthma].
Xymedone produced therapeutic effect in patients with atopic bronchial asthma. The drug action was manifested by a decrease in the IgE level and an increase in gamma-interferon level. Adding xymedone to lymphocytes cultivated with phytohemagglutinin revealed stimulating action of this drug on the delayed-type hypersensitivity. Mechanisms involved in the immunotropic action of xymedone are discussed.
Skorokhodkina
O V
OV
Tsibul'kin
A P
AP
Tsibul'kina
V N
VN
D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D000328:Adult; D001249:Asthma / Q000097:blood / Q000188:drug therapy*; D016207:Cytokines / Q000097:blood; D005260:Female; D006801:Humans; D008297:Male; D011743:Pyrimidines / Q000008:administration & dosage*
D000276:Adjuvants, Immunologic; D016207:Cytokines; D011743:Pyrimidines; C069705:xymedon